Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Survivin is highly expressed in CD34 + 38 − leukemic stem/progenitor cells and predicts poor clinical outcomes in AML

Bing Z. Carter, Yihua Qiu, Xuelin Huang, Lixia Diao, Nianxiang Zhang, Kevin R. Coombes, Duncan H. Mak, Marina Konopleva, Jorge Cortes, Hagop M. Kantarjian, Gordon B. Mills, Michael Andreeff, Steven M. Kornblau

Blood (2012) 120 (1): 173–180.

https://doi.org/10.1182/blood-2012-02-409888

Published: 2012

Includes: Supplemental data

Journal Articles

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Mary E Irwin, PhD, Laura Nelson, PhD, Janice M Santiago-O'Farrill, Claudia P Miller, PhD, Doris R. Siwak, PhD, Gordon B. Mills, MD, PhD, Shulin Li, PhD, Dennis P Hughes, MD, PhD, Joya Chandra, PhD

Blood (2011) 118 (21): 1397.

https://doi.org/10.1182/blood.V118.21.1397.1397

Published: 2011

Journal Articles

Functional proteomic profiling of AML predicts response and survival

Steven M. Kornblau, Raoul Tibes, Yi Hua Qiu, Wenjing Chen, Hagop M. Kantarjian, Michael Andreeff, Kevin R. Coombes, Gordon B. Mills

Blood (2009) 113 (1): 154–164.

https://doi.org/10.1182/blood-2007-10-119438

Published: 2009

Includes: Supplemental data

Journal Articles

Protein Expression Signatures Determined by Reverse Phase Proteins Arrays (RPPA) Accurately Predict FLT3-ITD Mutation Status in AML.

Steven M. Kornblau, MD, YiHua Qiu, MD, Wenjing Chen, MD, Srdan Verstovsek, MD, Kevin R. Coombes, PhD, Gordon B. Mills, MD, PhD

Blood (2007) 110 (11): 2398.

https://doi.org/10.1182/blood.V110.11.2398.2398

Published: 2007

Journal Articles

High Throughput Proteomic Analysis of 559 Acute Myelogenous Leukemia (AML) Patient Samples on a Single Slide Using Reverse Phase Proteins Arrays (RPPA): Analysis of Signal Transduction Pathway (STP) and Apoptosis Regulating Proteins.

Steven M. Kornblau, MD, YiHua Qiu, MD, MS, Raoul Tibes, MD, Wenjing Chen, MD, MS, Elizabeth Lemker, Michael Andreeff, MD, PhD, Kevin R. Coombes, PhD, Gordon B. Mills, MD, PhD

Blood (2006) 108 (11): 107.

https://doi.org/10.1182/blood.V108.11.107.107

Published: 2006

Journal Articles

G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth

Quan-sheng Zhu, Ling Xia, Gordon B. Mills, Clifford A. Lowell, Ivo P. Touw, Seth J. Corey

Blood (2006) 107 (5): 1847–1856.

https://doi.org/10.1182/blood-2005-04-1612

Published: 2006

Journal Articles

Time Course Proteomic Profiling of Signal Transduction and Apoptosis Pathways in AML Survivor Cells Using Reverse Phase Protein Lysate Microarray (RPPA) Reveals Differential Effect of Time, Dose and Agent(s).

Steven M. Kornblau, MD, YiHua Qiu, MD, Raoul Tibes, MD, Yiling Lu, MD, Gordon B. Mills, MD. PhD

Blood (2005) 106 (11): 1219.

https://doi.org/10.1182/blood.V106.11.1219.1219

Published: 2005

Journal Articles

Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA).

Raoul Tibes, MD, YiHua Qiu, MD, Kevin R. Coombes, Ph.D, David Gold, PhD, Gordon B. Mills, MD., PhD, Steven M. Kornblau, MD

Blood (2005) 106 (11): 484.

https://doi.org/10.1182/blood.V106.11.484.484

Published: 2005

Journal Articles

Differential Effects of Three Small Molecules Blocking Phosphatidylinositol-3 Kinase or AKT in Hodgkin Disease Cell Lines: Induction of Apoptosis and Cell Cycle Arrest.

Georgios V. Georgakis, MD, Yang Li, MSc, Georgios Z. Rassidakis, MD, Jeffrey L. Medeiros, MD, Gordon B. Mills, MD, PhD, Anas Younes, MD

Blood (2004) 104 (11): 428.

https://doi.org/10.1182/blood.V104.11.428.428

Published: 2004

Journal Articles

Mesenchymal Stem Cells Promote Survival of Leukemic Cells Via Integrin-Linked Kinase (ILK)-Dependent Akt and STAT3 Activation: Implications for Leukemia Therapy.

Yoko Tabe, M.D., Ph.D., Linhua Jin, Gordon B. Mills, M.D., Ph.D., Yuko Tsutsumi-Ishii, Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.

Blood (2004) 104 (11): 3377.

https://doi.org/10.1182/blood.V104.11.3377.3377

Published: 2004

NARROW

Survivin is highly expressed in CD34 + 38 − leukemic stem/progenitor cells and predicts poor clinical outcomes in AML

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Functional proteomic profiling of AML predicts response and survival

Protein Expression Signatures Determined by Reverse Phase Proteins Arrays (RPPA) Accurately Predict FLT3-ITD Mutation Status in AML.

High Throughput Proteomic Analysis of 559 Acute Myelogenous Leukemia (AML) Patient Samples on a Single Slide Using Reverse Phase Proteins Arrays (RPPA): Analysis of Signal Transduction Pathway (STP) and Apoptosis Regulating Proteins.

G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth

Time Course Proteomic Profiling of Signal Transduction and Apoptosis Pathways in AML Survivor Cells Using Reverse Phase Protein Lysate Microarray (RPPA) Reveals Differential Effect of Time, Dose and Agent(s).

Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA).

Differential Effects of Three Small Molecules Blocking Phosphatidylinositol-3 Kinase or AKT in Hodgkin Disease Cell Lines: Induction of Apoptosis and Cell Cycle Arrest.

Mesenchymal Stem Cells Promote Survival of Leukemic Cells Via Integrin-Linked Kinase (ILK)-Dependent Akt and STAT3 Activation: Implications for Leukemia Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only